143 related articles for article (PubMed ID: 21049307)
1. Imunoexpression of Ki-67 and p53 in rectal cancer tissue after treatment with neoadjuvant chemoradiation.
Andrade NR; Oshima CT; Gomes TS; Neto RA; Forones NM
J Gastrointest Cancer; 2011 Mar; 42(1):34-9. PubMed ID: 21049307
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
[TBL] [Abstract][Full Text] [Related]
3. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
4. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
[TBL] [Abstract][Full Text] [Related]
5. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer.
Esposito G; Pucciarelli S; Alaggio R; Giacomelli L; Marchiori E; Iaderosa GA; Friso ML; Toppan P; Chieco-Bianchi L; Lise M
Ann Surg Oncol; 2001 May; 8(4):311-8. PubMed ID: 11352304
[TBL] [Abstract][Full Text] [Related]
6. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
[TBL] [Abstract][Full Text] [Related]
7. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
[TBL] [Abstract][Full Text] [Related]
10. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant radiochemotherapy for rectal cancer].
Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
[No Abstract] [Full Text] [Related]
12. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
Balboa E; Duran G; Lamas MJ; Gomez-Caamaño A; Celeiro-Muñoz C; Lopez R; Carracedo A; Barros F
Pharmacogenomics; 2010 Jun; 11(6):747-61. PubMed ID: 20504250
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
[TBL] [Abstract][Full Text] [Related]
15. Effects of pharmacokinetic modulating chemotherapy using oral UFT and continuous venous 5FU infusion on the prognosis of irradiated rectal carcinomas with p53 overexpression.
Kusunoki M; Yanagi H; Kotera H; Noda M; Yamamura T
Int J Oncol; 1998 Oct; 13(4):653-7. PubMed ID: 9735391
[TBL] [Abstract][Full Text] [Related]
16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.
Gasparini G; Torino F; Ueno T; Cascinu S; Troiani T; Ballestrero A; Berardi R; Shishido J; Yoshizawa A; Mori Y; Nagayama S; Morosini P; Toi M
Angiogenesis; 2012 Mar; 15(1):141-50. PubMed ID: 22212406
[TBL] [Abstract][Full Text] [Related]
18. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
Kelley ST; Coppola D; Yeatman T; Marcet J
Clin Colorectal Cancer; 2005 Jul; 5(2):114-8. PubMed ID: 16098252
[TBL] [Abstract][Full Text] [Related]
19. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
